1 in 9 persons tested found positive for infectious disease in ICMR study

New Delhi: Pathogens were found in 11.1 % of the 4.5 lakh patients tested by the network of labs under the Indian Council of Medical Research as part of efforts to identify viral infections of public health significance.

The top five pathogens detected were Influenza A in acute respiratory infection (ARI)/ severe acute respiratory infections (SARI cases), dengue virus among acute fever and haemorrhagic fever cases, Hepatitis A in jaundice cases, Norovirus in among acute diarrhoeal disease (ADD) outbreaks and Herpes simplex virus (HSV) in Acute Encephalitis Syndrome (AES) cases.

The spread of infectious diseases rose from 10.7 % in the first quarter to 11.5 % in the second quarter of 2025, according to the report by the Indian Council of Medical Research (ICMR). According to the Virus Research and Diagnostic Laboratories (VRDL) network of ICMR, between January and March, out of 2,28,856 samples, 24,502 (10.7 %) were found to contain pathogens from April to June 2025, 26,055 (11.5 %) out of 2,26,095 samples tested positive. Thus, the infection rate rose by 0.8 percentage points over the previous quarter, signalling the need for stronger monitoring of infection trends.

According to a senior scientist while this increase may not appear large, it should not be underestimated – it could serve as a warning for seasonal diseases and emerging infections.

If we continue tracking quarterly changes in infection rates, future epidemics could be prevented in time. The VRDL network acts as an early warning system for the country.

The ICMR report found that between April and June this year, 191 disease cluster were investigated and infectious diseases such as mumps, measles, rubella, dengue, chikungunya, rotavirus, norovirus, varicella zoster virus, Epstein-Barr virus (EBV) and astrovirus were identified.

Between January and March, 389 disease clusters were investigated and infectious diseases such as mumps, measles, rubella, hepatitis, dengue, chikungunya, rotavirus, influenza, Leptospira, Varicella zoster virus and Sexually transmitted infections (STIs) were identified.

From 2014-2024, more than 40 lakh samples were tested with pathogen identified in 18.8 %.

The VRDLN expanded from 27 laboratories in 2014 to 165 laboratories across 31 states and UTs by 2025. Through this network, 2,534 disease clusters have been identified across the country so far.

Related Posts

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Drug Controller Ajay Phatak said that the Bupivacaine Hydrochloride in Dextrose, manufactured by Themis Medicare Limited, Batch No. BKP02601 has been restricted for sale and use. The Rajasthan Drug…

Raj orders statewide inspection of blood centres for compliance with safety norms

Jaipur: Rajasthan’s Health Department, Wednesday, ordered intensified inspections of all govt, non-govt and private blood centres after repeated violations of safety and operational norms. Recent inspections led to suspension of 69 licences…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Raj orders statewide inspection of blood centres for compliance with safety norms

Raj orders statewide inspection of blood centres for compliance with safety norms

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

Telangana bets big on drug discovery hub

Telangana bets big on drug discovery hub

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery